Fri 12/14/2018 11:49 ET
S&P 5002614.0036.071.38%BANKS400.301.000.25%OIL51.201.382.70%BITCOIN3219.3783.382.59%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Pressure BioSciences - PBIO)    Stock Due Diligence for All

Return Top | Return List | Reply Thread | Search | Add PBIO | Ignore PBIO
From: NetworkNewsWire (Rep: 0)Date: 2017-11-14 20:01:36
Forum: Wall Street Pit - Thread #673966269 - List PBIO msgsMsg #2701467 - Part 1/1 (Rec: 0)
NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Posts Q3 2017 Financial Results, Provides Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”) reported financial results for the third quarter of 2017 today, along with a business update and limited guidance regarding its expected revenue for the rest of FY 2017. Among other highlights, the company reported a record-breaking total revenue of $646,061, an increase of 21% from $535,334 in the third quarter of 2016. The company also gained increases in products & services revenue, consumable sales and grant revenue. During the quarter, PBI also completed the hiring of its new 5-person field sales team and filled its Director of Sales North America position. "We believe the revenue growth reported in the third quarter and year-to-date will not only continue in Q4 2017 and beyond, but will accelerate to an even greater rate as our new sales team begins to meet with existing and potential customers throughout the U.S.," PBI VP of finance and CFO Joseph L. Damasio, Jr. stated in the news release. Additionally, PBI will be holding a conference call to discuss the financial results today at 4:30pm EST. To join the conference, dial the North American number, (877) 407-8031 or the international number, (201) 689-8031. The verbal passcode will be “PBIO Third Quarter 2017 Financial Call.” The call will also be available for replay on the company’s website.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:
Message: Endorse | Reply | Privately | Bookmark | Report Abuse User NetworkNewsWire: Reward | Watch | Ignore | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999-, Inc.